Automating Office Ally Cosentyx Prior Authorization

Klivira streamlines the complex process of Office Ally Cosentyx prior authorization, transforming manual workflows into efficient, automated submissions. We integrate directly with your Office Ally EHR to accelerate approvals for secukinumab.

For revenue cycle directors and prior authorization coordinators utilizing Office Ally, managing specialty drug PAs like Cosentyx presents a significant administrative burden. The need to accurately extract clinical data, determine benefit type, and submit timely requests can lead to delays and denials. Klivira addresses these challenges by automating key steps in the Office Ally Cosentyx prior authorization workflow.

Navigating Cosentyx Prior Authorization within Office Ally

When Cosentyx (secukinumab) is ordered within the Office Ally EHR, the prior authorization process typically initiates a series of manual steps. This often involves extracting patient demographics, clinical notes, and medication history from various sections of the EMR to complete payer-specific forms. Klivira intercepts this workflow at the point of order entry, automating the data aggregation required for an efficient ePA submission.

Differentiating Pharmacy and Medical Benefit for IL-17A Inhibitors

Specialty drugs like Cosentyx, an IL-17A inhibitor, can fall under either the pharmacy benefit (e.g., self-administered retail prescription) or the medical benefit (e.g., administered in-office). Office Ally's integrated practice management system provides the necessary billing and encounter data. Klivira leverages this information to accurately determine the appropriate benefit pathway, ensuring the correct X12 278 or NCPDP SCRIPT ePA submission is initiated, reducing misrouting and delays.

Intelligent Data Extraction from Office Ally Clinical Documentation

Klivira's platform is engineered to intelligently pull relevant clinical documentation from Office Ally's EHR to support Cosentyx prior authorizations. This includes extracting key diagnostic criteria for psoriasis, psoriatic arthritis, or ankylosing spondylitis from the problem list, progress notes, and medication history. We identify evidence of previous treatments, disease severity, and contraindications, ensuring the submitted PA package meets payer medical necessity requirements.

Klivira's Seamless Integration with Office Ally for ePA

Klivira integrates with Office Ally using established APIs and clearinghouse functionalities, ensuring a secure and efficient data exchange. This allows for the automated initiation and submission of prior authorization requests for Cosentyx directly from your Office Ally environment. Our system translates relevant clinical data into structured formats compliant with standards like X12 278 and NCPDP SCRIPT, minimizing manual data entry and improving data accuracy.

Enhancing Prior Authorization Efficiency for Office Ally Users

By automating the Office Ally Cosentyx prior authorization process, Klivira significantly reduces the administrative burden on your staff. This translates to faster turnaround times for secukinumab approvals, improved PA denial rates, and allows your prior authorization coordinators to focus on complex cases rather than routine data entry. The result is improved patient access to critical therapies and enhanced revenue cycle performance.

Frequently asked questions

How does Klivira integrate with Office Ally for Cosentyx prior authorizations?

Klivira integrates with Office Ally through secure APIs and existing clearinghouse connections. This allows us to capture Cosentyx orders and extract necessary clinical documentation from the EHR, then structure and submit the prior authorization request via X12 278 or NCPDP SCRIPT ePA directly to payers.

Does Klivira handle both pharmacy and medical benefit PAs for Cosentyx ordered in Office Ally?

Yes, Klivira is designed to differentiate between pharmacy and medical benefit prior authorizations for specialty drugs like Cosentyx. Our system analyzes the order and patient context within Office Ally to determine the correct benefit pathway, ensuring the appropriate ePA standard is used for submission.

What specific documentation does Klivira extract from Office Ally to support Cosentyx PAs?

Klivira extracts relevant clinical data from Office Ally, including diagnoses from the problem list (e.g., psoriasis, psoriatic arthritis), details from progress notes regarding disease activity and previous therapies, and medication history. This ensures comprehensive data submission to meet payer medical necessity criteria for secukinumab.

Can Klivira help reduce Cosentyx prior authorization denial rates for Office Ally users?

Yes, by ensuring accurate and complete clinical documentation is submitted with each Cosentyx prior authorization request, Klivira helps reduce common reasons for denials. Our automation minimizes human error and ensures all payer-specific requirements are addressed, improving the likelihood of initial approval.

Is patient health information (PHI) secure when integrating Office Ally with Klivira for prior authorizations?

Absolutely. Klivira adheres to stringent security protocols and is fully HIPAA compliant. All data exchange between Office Ally and Klivira is encrypted and handled with the utmost care to protect ePHI throughout the entire prior authorization process.

Related coverage

Other office-ally prior auth coverage

Ready to automate prior auth for this integration?

See how Klivira automates prior authorizations for your team.

Request a demo